Use of dimethyl sulfoxide (DMSO) in radiation therapy (in German)
Journal Article
·
· Radiobiol.-Radiother., v. 14, no. 5, pp. 471-479
OSTI ID:4328206
The present clinical examinstion deals with the possible use of DMSO in rsdiation therapy. DMSO was applied to 30 patients, 8 times in radiogenic subcutaneous fibroses, 13 times in contracted scars and keloids, 3 times in cases of induratio penis plastica, and 6 times as vehicle substsnce for tamor cell sensitization with vitamin A in the radiation therapy of skin metastases sfter mamma carcinoma. The results confirm the value of a DMSO treatment of subcutaneous fibroses following highly dosed percutaneous radiation therapy, especially in cases with a radiological ulcer. In keloids of scars a clear effect could be achieved without exceptions also in those csses showing only insufficient regression tendency to a preceded rsdiation therapy. The results of irradiation in cases with I.p.p., however, did not show any convincing improvement by a DMSO treatment. A new field of application is opened for the indiation therapy of recurrences and metastases in the area of the skin by sensitization of these cutaneous tumor infiltrates by vitamin A in connection with DMSO as vehicle substance so that a curative regression can be locally obtained by relatively low radiation doses. (auth)
- Research Organization:
- Martin Luther Univ., Halle, Ger.
- NSA Number:
- NSA-29-021171
- OSTI ID:
- 4328206
- Journal Information:
- Radiobiol.-Radiother., v. 14, no. 5, pp. 471-479, Journal Name: Radiobiol.-Radiother., v. 14, no. 5, pp. 471-479; ISSN RDBGA
- Country of Publication:
- Country unknown/Code not available
- Language:
- German
Similar Records
ELECTRON MICROSCOPIC STUDIES ON KELOID FOLLOWING ATOMIC BOMB INJURIES
Reduced growth factor requirement of keloid-derived fibroblasts may account for tumor growth
Perioperative Interstitial High-Dose-Rate Brachytherapy for the Treatment of Recurrent Keloids: Feasibility and Early Results
Journal Article
·
Thu Jan 01 04:00:00 UTC 1959
· Saihokaku Kagakukyokai Simposia
·
OSTI ID:4834778
Reduced growth factor requirement of keloid-derived fibroblasts may account for tumor growth
Journal Article
·
Fri Jan 01 04:00:00 UTC 1988
· Proc. Natl. Acad. Sci. U.S.A.; (United States)
·
OSTI ID:6142630
Perioperative Interstitial High-Dose-Rate Brachytherapy for the Treatment of Recurrent Keloids: Feasibility and Early Results
Journal Article
·
Tue Mar 01 04:00:00 UTC 2016
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:22645102